Adam May (@a_may_md) 's Twitter Profile
Adam May

@a_may_md

I invest in biotechs. I often tweet about companies I have positions in. Nothing I say should be considered investment advice.

ID: 940047237240971264

calendar_today11-12-2017 02:35:01

6,6K Tweet

7,7K Followers

90 Following

Adam May (@a_may_md) 's Twitter Profile Photo

Hahaha check this out $HIMS trolls! $LLY CEO (who also owns multiple hundreds of millions of dollars of company stock) is open market BUYING over a million dollars of $LLY shares. 3 other execs/insiders also joined him in 6-7 figure open market buys. THAT is how you want

Adam May (@a_may_md) 's Twitter Profile Photo

Even a few $HIMS bulls out there are wising up to the clear growth deceleration and what it means for the company. If there was some magic new vertical that would come in and immediately save $HIMS’ stalling growth, they’d have launched it by now. Keep ignoring the data at

Adam May (@a_may_md) 's Twitter Profile Photo

$LLY showing us how the MFN scare will be handled! IMO this approach will qualm some fears for $LLY and other pharmas. msn.com/en-gb/health/o…

Adam May (@a_may_md) 's Twitter Profile Photo

Based on how $HIMS pushes clearly past the proper boundaries in medicine, it would not surprise me AT ALL if the FTC is able to nail them on some BS that they're pulling with their cancellation practices.

Adam May (@a_may_md) 's Twitter Profile Photo

Also, U.S. FDA the FTC is out here doing their job. Where the hell are you? You should have been on top of the $HIMS mass-personalization GLP-1 compounding scam months ago. The FTC is protecting consumers. Are you really going to allow these telehealth companies to

Adam May (@a_may_md) 's Twitter Profile Photo

Respect Skorpion and their work but I did buy a little of the $SLNO dip. Pulmonary edema is a well characterized adverse event with diazoxide…The FDA knew this all during the approval process and I’m not convinced the rates the real world is showing deviate from what was

Adam May (@a_may_md) 's Twitter Profile Photo

Biggest beneficiary of FDA’s more “lenient” commentary on yesterday night’s $PGEN approval? $IOBT $REPL $SRPT $CAPR

Adam May (@a_may_md) 's Twitter Profile Photo

It isn't on the $HIMS SEC page yet, but it does appear that $HIMS CEO is making another stock sale today. This time for nearly $6M selling at around $45/share. Right on the heels of the >$30M sale also this month. Today's is likely "pre-planned", but...is the $HIMS cult really